The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Orege SA
PAR:OREGE
|
FR |
|
N
|
NVIDIA Corp
F:NVD
|
US |
|
I
|
IQuest Co Ltd
KOSDAQ:262840
|
KR |
|
BeOne Medicines AG
F:49BA
|
CH |
|
C
|
China Coal Energy Co Ltd
XMUN:CVV
|
CN |
|
UOB-Kay Hian Holdings Ltd
SGX:U10
|
SG |
|
First Robinson Financial Corp
OTC:FRFC
|
US |
|
Naturgy Energy Group SA
F:GANA
|
ES |
|
W
|
Wells Fargo & Co
BMV:WFC
|
US |
|
I
|
INNOAX Co Ltd
KOSDAQ:296640
|
KR |
|
Brown-Forman Corp
NYSE:BF.B
|
US |
|
S
|
Shin-Etsu Chemical Co Ltd
OTC:SHECF
|
JP |
|
O
|
OneSpan Inc
F:VDY
|
US |
|
Fortuna Mining Corp
TSX:FVI
|
CA |
|
S
|
Shin-Etsu Chemical Co Ltd
XMUN:SEH
|
JP |
|
Lucid Group Inc
F:CH2
|
US |
|
A
|
Abbott Laboratories
XMUN:ABL
|
US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
US |
|
Severn Trent PLC
F:SVT
|
UK |
|
Man Wah Holdings Ltd
F:AAM
|
HK |
|
Medistim ASA
OSE:MEDI
|
NO |
|
U
|
United Parcel Service Inc
XMUN:UPAB
|
US |
|
First Quantum Minerals Ltd
TSX:FM
|
CA |
|
Bollinger Innovations Inc
F:1N5
|
US |
Orege SA (OREGE)’s 12-month stock price forecast through November 2027 has a consensus target of €0.204, implying 27% downside. The forecast is based on price targets from 3 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
OREGE is 0.204 EUR with a low forecast of 0.202 EUR and a high forecast of 0.21 EUR.
Over the last 11 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 4 years is 36%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more